Overcoming the Safety Challenges of Aldose Reductase Inhibition: Development of AT-001 for Diabetic Cardiomyopathy
Metabolism: Clinical and Experimental - Netherlands
doi 10.1016/j.metabol.2019.12.060
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2020
Authors
Publisher
Elsevier BV